Taiyen Biotech CoTPE:1737 83 Net Margin % is 17.53% as of Dec. 2025, which is 48% above its 10-year median of 11.85. GuruFocus rates TPE:1737 with a GF Score™ of 83/100 and a GF Value™ of NT$32.09 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,946 Consumer Packaged Goods companies, Taiyen Biotech Co ranks better than 85.1% on this metric.
The historical rank and industry rank for Taiyen Biotech Co's Net Margin % or its related term are showing as below:
TPE:1737'
s Net Margin % Range Over the Past 10 Years
Min: 8.81 Med: 11.85 Max: 15.08
Current: 12.09
TPE:1737's Net Margin % is ranked better than 85.1% of 1946
companies
in the Consumer Packaged Goods industry
Industry Median: 3.48
vs TPE:1737: 12.09
Taiyen Biotech Co (TPE:1737) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Taiyen Biotech Co Net Margin % Related Terms
Taiyen Biotech Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co Net Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiyen Biotech Co (TPE:1737) has a Net Margin % of 17.53% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Taiyen Biotech Co and its competitors. This is 48% above median its historical median of 11.85. Over the past decade, Taiyen Biotech Co's Net Margin % has ranged from 8.81 to 15.08. According to the industry distribution chart, Taiyen Biotech Co ranks #290 out of 1946 companies in the Consumer Packaged Goods industry, placing it in the top 14.9%.
Is Taiyen Biotech Co's Net Margin % too high?
Taiyen Biotech Co's current Net Margin % of 17.53% is 48% above median its 10-year median of 11.85. Over the past 10 years, this metric has ranged from a low of 8.81 to a high of 15.08. The Consumer Packaged Goods industry median Net Margin % is 3.48. Taiyen Biotech Co's value of 17.53% is 403.7% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #290 out of 1946 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Taiyen Biotech Co has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Net Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #290 out of 1946 companies for Net Margin %. This places Taiyen Biotech Co in the top 15% of its industry — outperforming the majority of peers. The industry median Net Margin % is 3.48. Taiyen Biotech Co's value of 17.53% is 403.7% above this benchmark. Historically, Taiyen Biotech Co's own Net Margin % has ranged from 8.81 to 15.08 over the past decade. While the company's 10-year median is 11.85 vs. the industry median of 3.48, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Consumer Packaged Goods company?
The median Net Margin % among Consumer Packaged Goods companies is 3.48, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current Net Margin % of 17.53% is 403.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Net Margin % is 3.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current Net Margin % is 17.53%, which is 48% above median its own 10-year median of 11.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.09, compared to a current price of NT$31.90 — trading 0.6% below its estimated fair value. The current Net Margin % is 17.53%, which is 48% above median its 10-year median of 11.85 and 403.7% above the Consumer Packaged Goods industry median of 3.48. Taiyen Biotech Co's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Net Margin % is 17.53% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$31.90 is trading 0.6% below its estimated GF Value™ of NT$32.09.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
Net Margin %: 17.53% (48% above median its 10-year median of 11.85)
GF Value™: NT$32.09 vs. price of NT$31.90 (0.6% below fair value)
Industry Position: 403.7% above the Consumer Packaged Goods median (#290 of 1946)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
83GF Score
Get the complete analysis for TPE:1737
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
